Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.041627 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Rosa Lillo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Cardiovascolari-CUORE Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy. Hauptthemen laut MEDLINE: Echocardiography, Fabry Disease, Hypertrophy, Left Ventricular, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Fabry disease can be classified in 4 stages based on the extent of cardiac damage assessed with echocardiography. This staging is strongly associated with prognosis, with a doubled risk increase of cardiovascular events for each stage progression. The aims of the present study were to investigate the evolution of cardiac damage using this staging system during midterm follow‐up and to identify predictors of stage worsening.
Methods
AND RESULTS This is a retrospective, multicenter study, which included 168 patients with Fabry disease (38% men) categorized at baseline and follow‐up in 4 stages, defined as follows: stage 0, no cardiac involvement; stage 1, left ventricular hypertrophy; stage 2, left atrial enlargement; and stage 3, ventricular impairment. After a median of 5 years, cardiac stage worsened of at least 1 class in 34 patients (24% of 143 patients in stage 0–2 at baseline), improved in 9 (12% of 73 patients in stages 1–3 at baseline), and remained stable in 125 (74% of the 168 patients enrolled). At multivariable logistic regression analysis, age (odds ratio, 1.05 [95% CI, 1.01–1.09]; P =0.006), male sex (odds ratio, 4.26 [95% CI, 1.54–11.79]; P =0.005), classic phenotype (odds ratio, 4.95 [95% CI, 1.30–18.72]; P =0.018), and renal failure (odds ratio, 10.40 [95% CI, 1.57–68.77]; P =0.015) emerged as independent predictors of cardiac damage stage deterioration.
Conclusions
Fabry disease is associated with a high rate of progression of cardiac damage during midterm follow‐up, with ≈24% of patients experiencing cardiac stage worsening. Age, male sex, classic phenotype, and renal failure are independent predictors of stage progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dipartimento di Scienze Cardiovascolari-CUORE Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy.
- Facoltà di Medicina e Chirurgia, Dipartimento di Scienze Cardiovascolari-CUORE Università Cattolica del Sacro Cuore Rome Italy.
- Cardiomyopathy Unit, Careggi University Hospital, Department of Clinical and Experimental Medicine University of Florence Florence Italy.
- Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences University of Campania "Luigi Vanvitelli", Monaldi Hospital Naples Italy.
- Cardiology Unit, Cardiac Thoracic and Vascular Department IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.
- European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart.
ORCID-Profile: Rosa Lillo, Maria Chiara Meucci, Annamaria Del Franco, Emanuele Monda, Raffaello Ditaranto, Federico Di Nicola, Antonella Lombardo, Letizia Spinelli, Elena Biagini, Francesco Cappelli, Iacopo Olivotto, Maurizio Pieroni, Francesco Burzotta, Francesca Graziani
Zitieren
APA
Lillo, R., Meucci, M. C., Del Franco, A., Monda, E., Iannaccone, G., Ditaranto, R., Di Nicola, F., Serratore, S., Lombardo, A., Spinelli, L., Iaccarino, G., Biagini, E., Cappelli, F., Pisani, A., Limongelli, G., Olivotto, I., Pieroni, M., Burzotta, F., & Graziani, F. (2025). Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.041627
Vancouver
Lillo R, Meucci MC, Del Franco A, Monda E, Iannaccone G, Ditaranto R, et al. Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.041627
BibTeX
@article{Lillo2025,
author = {Lillo, Rosa and Meucci, Maria Chiara and Del Franco, Annamaria and Monda, Emanuele and Iannaccone, Giulia and Ditaranto, Raffaello and Di Nicola, Federico and Serratore, Serena and Lombardo, Antonella and Spinelli, Letizia and Iaccarino, Guido and Biagini, Elena and Cappelli, Francesco and Pisani, Antonio and Limongelli, Giuseppe and Olivotto, Iacopo and Pieroni, Maurizio and Burzotta, Francesco and Graziani, Francesca},
title = {Evolution of Cardiac Damage Staged With Echocardiography in Fabry Disease},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.041627}
}
EUVIMED